期刊文献+

LC-MS/MS法同时测定大鼠尿液中4种淫羊藿黄酮苷 被引量:1

Simultaneous Quantitative Determination of Four Epimedium Flavonoids in Rat Urine by LC-MS/MS
下载PDF
导出
摘要 目的应用高效液相色谱-串联质谱联用(LC-MS/MS)法建立大鼠尿液中朝藿定A、B、C及淫羊藿苷的同时测定方法,初步探讨淫羊藿提取物在大鼠体内的排泄规律。方法以人参皂苷Rg1为内标,选用Agilent Eclipse XDB-C_(18)色谱柱(2.1 mm×150 mm,5μm);流动相:乙腈-0.1%乙酸水(30∶70);流速:0.3 m L·min^(-1);柱温:40℃;采用电喷雾离子源(ESI)负离子多反应检测(MRM)模式测定。结果朝藿定A、B、C以及淫羊藿苷在1~500 ng·m L^(-1)浓度范围内线性关系良好,日内精密度(RSD)均小于7.4%,日间精密度(RSD)均小于12.7%。大鼠口服灌胃给予淫羊藿提取物36 h后朝藿定A、B、C及淫羊藿苷的平均尿累积排泄量/给药量比值不超过0.27‰,0.20‰,0.30‰和0.43‰。结论本研究建立的LC-MS/MS方法简便灵敏快速,适用于尿液中朝藿定A、B、C以及淫羊藿苷的同时测定及淫羊藿提取物尿排泄动力学研究的应用,研究结果显示淫羊藿提取物原形药物基本不经尿液排泄,提示肾排泄不是其主要消除途径。 Objective To establish a liquid chromatography-mass spectrometry/mass spectrometry(LC-MS/MS)method for the simultaneous analysis of epimedin A,epimedin B,epimedin C and icariin in rat urine. Methods Ginsenoside Rg1 was used as the internal standard(IS). Chromatographic separation was carried out on an Agilent Eclipse XDB-C_(18)column(2.1 mm×150 mm,5 μm) by isocratic elution with 32 % acetonitrile and 68 % water containing 0.1 % acetic acid at a flow rate of 0.3 m L·min^(-1). The quantification of the analytes was performed by mass spectrometry with electrospray ionization(ESI)inlet and negative ion multiple reaction monitoring(MRM)mode. Results The calibration curves of epimedin A,epimedin B,epimedin C and icariin were linear in the range of 1~500 ng·m L^(-1). The intra-day precision of this method was less than 7.4 %,and the inter-day precision was less than 12.7 %. The ratio of mean urine cumulative excretion of the four analytes 36 h after intragastric administration to the administration dosage was 0.27 ‰, 0.20 ‰, 0.30 ‰, 0.43 ‰, respectively. Conclusion The established assay method is simple and convenient,which is suitable for the simultaneous measurement of urine epimedin A,epimedin B,epimedin C and icariin concentration in rats,and for the study of urine excretion kinetics of Herba Epimedii extract. The results showed that unchanged analytes of Herba Epimedii extract are hardly eliminated through urine in rats,indicating that renal excretion may not be the major elimination method for Herba Epimedii extract.
出处 《中药新药与临床药理》 CAS CSCD 北大核心 2016年第4期537-541,共5页 Traditional Chinese Drug Research and Clinical Pharmacology
关键词 高效液相色谱-串联质谱联用法 淫羊藿提取物 淫羊藿黄酮 尿药浓度 尿排泄 LC-MS/MS Herba Epimedii extract Epimedium flavonoids urine concentration urine excretion
  • 相关文献

参考文献11

  • 1张玉萱,徐玲玲.淫羊藿总黄酮的药理作用研究进展[J].实用临床医药杂志,2012,16(9):125-128. 被引量:21
  • 2武敬亮,苏智先,田桂香,张璟霞.淫羊藿研究新进展[J].中医药学报,2004,32(3):69-72. 被引量:31
  • 3马慧萍,贾正平,葛欣,何晓英,陈克明,白孟海.淫羊藿总黄酮抗大鼠实验性骨质疏松作用研究[J].华西药学杂志,2002,17(3):163-167. 被引量:70
  • 4蒋凌云,刘光明,陈可欣.淫羊藿苷的提取、分离和抗肿瘤作用机制的研究进展[J].现代药物与临床,2011,26(5):353-358. 被引量:15
  • 5Zhang HF, Yang TS, Li ZZ, et al. Simultaneous extraction of epimedin A, B, C and ieariin from Herba Epimedii by ultrasonic technique[J]. Ultrasonics Sonochemistry, 2008, 15(4): 376-385.
  • 6Meng FH, Li YB, Xiong ZL, et al. Osteoblastic proliferative activity of Epimedium brevicornum Maxim [J]. Phytomedicine, 2005, 12 ( 3 ) : 189-193.
  • 7Zhang X, Li Y, Yang X, et al. Inhibitory effect of Epimedium extract on S-adenosyl-L-homocysteine hydrolase and biomethylation [J]. Life Sciences, 2005, 78(2): 180-186.
  • 8Zhu D, Qu L, Zhang X, et al. Ieariin-mediated modulation of cell cycle and p53 during cardiomyocyte differentiation in embryonic stem cells[J]. European Journal of Pharmacology, 2005, 514( 2-3 ) : 99-110.
  • 9Li Y, Xiong Z, Li F. Determination of epimedin C in rat plasma by reversed-phase high-performance chromatography after oral adminis- tration of Herba Epimedii extract [J]. Journal of Chromatography B, 2005, 821(2): 235-239.
  • 10I~e CJ, Wu YT, Hsueh TY, et al. Pharmacokinetics and oral bioavailability of epimedin C "after oral administration of epimedin C and Herba Epimedii extract in rats [J]. Biomedieal Chromatography, 2014, 28(5): 630-636.

二级参考文献86

共引文献129

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部